Literature DB >> 23279565

Asian ethnicity in systemic lupus erythematosus: an Australian perspective.

K Connelly1, E F Morand, A Y Hoi.   

Abstract

Ethnic differences in both disease susceptibility and expression have been noted in systemic lupus erythematosus (SLE). This review focuses on the evidence of disparities between SLE patients of Asian and Caucasian descent, the two predominant ethnic groups affected by SLE in the Australian context. While epidemiological studies suggest higher rates of SLE among Asian patients, multi-ethnic cohort studies have allowed direct comparison of disease characteristics between different ethnic groups. Such studies suggest that Asians are affected by more severe SLE across several disease parameters, including increased renal involvement, autoantibody positivity, disease activity and damage accumulation. As delineation of these disparities becomes clearer, uncovering the biological basis of such differences poses a significant opportunity to progress understanding of SLE pathogenesis. Understanding ethnic variation in disease provides a platform for an individualised approach to risk assessment, monitoring and management of SLE.
© 2012 The Authors; Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2013        PMID: 23279565     DOI: 10.1111/imj.12070

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  11 in total

1.  Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Samira Alesaeidi; Jafar Karami; Mahdi Mahmoudi; Mahmoud Akbarian; Shiva Poursani; Azadeh Amirzadeh; Nazgol-Sadat Haddadi; Elahe Saffari; Ahmad Reza Jamshidi
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

2.  The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus.

Authors:  Amritha Budhoo; Girish M Mody
Journal:  Clin Rheumatol       Date:  2015-08-23       Impact factor: 2.980

Review 3.  Successes, challenges and developments in Australian rheumatology.

Authors:  Eric F Morand; Michelle T Leech
Journal:  Nat Rev Rheumatol       Date:  2015-03-10       Impact factor: 20.543

Review 4.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

5.  Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.

Authors:  Sidha Sreedharan; Ning Li; Geoff Littlejohn; Russell Buchanan; Mandana Nikpour; Eric Morand; Alberta Hoi; Vera Golder
Journal:  Arthritis Res Ther       Date:  2022-06-22       Impact factor: 5.606

Review 6.  Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies.

Authors:  Ziqian Wang; Yanhong Wang; Rongrong Zhu; Xinping Tian; Dong Xu; Qian Wang; Chanyuan Wu; Shangzhu Zhang; Jiuliang Zhao; Yan Zhao; Mengtao Li; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 7.  Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice.

Authors:  David A Hart
Journal:  Biol Sex Differ       Date:  2016-06-27       Impact factor: 5.027

8.  Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.

Authors:  K L Connelly; R Kandane-Rathnayake; A Hoi; Mandana Nikpour; E F Morand
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

Review 9.  Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?

Authors:  Jacqueline K Flynn; Wendy Dankers; Eric F Morand
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

10.  Association of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 polymorphisms with systemic lupus erythematosus disease activity and biomarker levels: A case-control study in Chinese population.

Authors:  Zhenzhen Su; Qian Niu; Zhuochun Huang; Bin Yang; Junlong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.